Exploring the relationship between Insulin resistance and interferon resistance: options to overcome Hepatitis C Virus (HCV) non-response to pegylated interferon.
Phase of Trial: Phase II
Latest Information Update: 28 Mar 2012
At a glance
- Drugs Pioglitazone (Primary) ; Peginterferon; Ribavirin
- Indications Hepatitis C; Insulin resistance
- Focus Therapeutic Use
- 01 Feb 2012 Status changed from recruiting to completed as reported by ISRCTN: Current Controlled Trials.
- 23 Jan 2010 New trial record